Listed

Nutex Health Inc.: Form 10-Q for the period ended Mar 31, 2014

Filed with the SEC on May 14, 2014 and accepted by EDGAR at May 14, 2014, 08:24 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2014-01-01 to 2014-03-31$240.2kus-gaap:SalesRevenueNet
Cost of revenue3 months2014-01-01 to 2014-03-31$102.9kus-gaap:CostOfRevenue
Gross profit3 months2014-01-01 to 2014-03-31$137.3kus-gaap:GrossProfit
Operating income3 months2014-01-01 to 2014-03-31−$135.0kus-gaap:OperatingIncomeLoss
Interest expense3 months2014-01-01 to 2014-03-31−$3.5kus-gaap:InterestExpense
Net income3 months2014-01-01 to 2014-03-31−$161.6kus-gaap:NetIncomeLoss
Diluted EPS3 months2014-01-01 to 2014-03-31−$0.01us-gaap:EarningsPerShareBasicAndDiluted
Diluted shares (weighted)3 months2014-01-01 to 2014-03-3125,044,056 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2014-01-01 to 2014-03-31$2.9kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2014-01-01 to 2014-03-31−$2.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment

Source: SEC EDGAR, the filing index for accession 0001211524-14-000053. Last ingested by Listed: Nov 14, 2026, 12:46 ET. Listed shows no prices and gives no investment advice.